SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 114 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,294,000 | +23.1% | 286,650 | 0.0% | 0.18% | +18.2% |
| Q1 2016 | $3,489,000 | -23.5% | 286,650 | 0.0% | 0.15% | -10.3% |
| Q4 2015 | $4,561,000 | -27.3% | 286,650 | -30.0% | 0.16% | -27.0% |
| Q3 2015 | $6,278,000 | -36.9% | 409,500 | 0.0% | 0.23% | -37.2% |
| Q2 2015 | $9,955,000 | +4.6% | 409,500 | 0.0% | 0.36% | -4.5% |
| Q1 2015 | $9,521,000 | +343.5% | 409,500 | +378.9% | 0.38% | +277.0% |
| Q4 2014 | $2,147,000 | -82.9% | 85,500 | -78.9% | 0.10% | -83.1% |
| Q3 2014 | $12,587,000 | +20.3% | 404,731 | 0.0% | 0.59% | -38.6% |
| Q2 2014 | $10,466,000 | +10.6% | 404,731 | 0.0% | 0.96% | +1.6% |
| Q1 2014 | $9,459,000 | +16.7% | 404,731 | +26.8% | 0.95% | +11.2% |
| Q4 2013 | $8,102,000 | +47.1% | 319,231 | +18.2% | 0.85% | +38.8% |
| Q3 2013 | $5,509,000 | -2.8% | 270,031 | 0.0% | 0.61% | -20.4% |
| Q2 2013 | $5,665,000 | – | 270,031 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|